Under Development

 
  • Abaloparatide
  • Ametinib
  • Brivarcetam
  • Carfilzomib
  • Dalbavancin
  • Edoxaban
  • Elacestrant
  • Eltrombopag
  • Etelcalcetide
  • Exatecan
  • Imeglimin
  • Isavuconazonium
  • Lenacapavir
  • Lurbinectedin
  • Orforglipron
  • Relebactam
  • Relugolix
  • Ruxolitinib
  • Selumetinib
  • Setmelanotide
  • Tegoprazan
  • Trabectedin
  • Trilaciclib
  • Ubrogepant
No results found

Products under patent are not offered for sales until patent expiration in the relevant country.